Keywords: vioxx, backed, approval, celebrex, gets, hit, side-effect
Vioxx backed for US approval, as Celebrex gets hit by side-effect concerns
Article | 21 April 1999
Major competition for Searle and Pfizer's selective cyclo-oxygenase-2inhibitor Celebrex (celecoxib) came a step nearer with an approval recommendation for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
